简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Leidos超越第三季度预期,提高2025年每股收益指引

2025-11-05 00:14

Leidos Holdings Inc. (NYSE:LDOS) shares are trading higher on Tuesday after the company reported better-than-expected third-quarter results and raised its full-year EPS guidance.

Details

The company reported quarterly revenue growth of 7% year over year (Y/Y) to $4.47 billion, beating the analyst consensus estimate of $4.28 billion.

Also Read: Leidos Bets On AI With VML To Strengthen US Defense

Revenues grew year-over-year due to increased demand across primarily for innovative products and solutions for national security and defense missions.

The company’s adjusted EPS was $3.05, up 4% Y/Y, beating the analyst consensus estimate of $2.71.

Adjusted EBITDA was $616 million, up 3% Y/Y; however, the margin of 13.8% declined from 14.2% a year ago. 

Net bookings totaled $5.9 billion for the quarter, representing a book-to-bill ratio of 1.3. 

As a result, the backlog at the end of the quarter was $47.7 billion (up 5% Y/Y), of which $9.1 billion was funded. 

Leidos held $974 million in cash and equivalents as of October 3, 2025.

Outlook Boost

Leidos raised FY25 adjusted EPS guidance to $11.45–$11.75 (from $11.15–$11.45) vs consensus of $11.56.

Meanwhile, the company maintained full-year sales guidance at $17.0 billion–$17.25 billion vs the street view of $17.179 billion.

Leidos CEO Tom Bell commented, “Despite the government shutdown, we are raising our 2025 earnings and margin guidance and holding firm on our 2025 revenue and cash guidance.”

Dividend Raised

On October 31, 2025, Leidos declared a quarterly cash dividend of $0.43 per share, up 7.5% from the prior quarter, payable on December 31 to shareholders of record on December 15, 2025.

Price Action: Leidos shares are trading higher by 5.93% at $204.50 at last check on Tuesday.

Read Next:

  • Elon Musk Says Head Of NASA Has ‘2 Digit IQ’ — SpaceX’s Moon Deal Hangs In Balance

Photo: Shutterstock

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。